These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 21750437)
41. [Management of hypertensive patients with cardiovascular damage]. Tomiyama H; Takata Y; Yamashina A Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444 [No Abstract] [Full Text] [Related]
42. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention. Talbert RL J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609 [TBL] [Abstract][Full Text] [Related]
43. Managing hypertension in patients with chronic kidney disease. Zuber K; Gilmartin C; Davis J JAAPA; 2014 Sep; 27(9):37-46. PubMed ID: 25148442 [TBL] [Abstract][Full Text] [Related]
45. [ALLHAT trial--antithesis to the overuse of vasodilating antihypertensive drugs]. Kuwajima I Nihon Rinsho; 2004 Mar; 62 Suppl 3():648-53. PubMed ID: 15171450 [No Abstract] [Full Text] [Related]
46. Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence. Bloch MJ; Basile JN J Clin Hypertens (Greenwich); 2011 Jan; 13(1):1-4. PubMed ID: 21214713 [No Abstract] [Full Text] [Related]
47. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension]. Higashiura K Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446 [No Abstract] [Full Text] [Related]
48. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker]. Einecke D MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923 [No Abstract] [Full Text] [Related]
49. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Polónia J; Barbosa L; Silva JA; Bertoquini S Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082 [TBL] [Abstract][Full Text] [Related]
50. [Persistence and adherence: Comparison between the five classes diuretics, beta-blocker, calcium channel blockers, ACE-inhibitors and angiotensin receptor blockers as the first line in antihypertensive therapy]. Rossol-Haseroth K; Eckes L; Schroeder A MMW Fortschr Med; 2011 Mar; 153 Suppl 1():21-5. PubMed ID: 21591327 [No Abstract] [Full Text] [Related]
51. Combination therapy in hypertension. Gorostidi M; de la Sierra A Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510 [TBL] [Abstract][Full Text] [Related]
52. Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes. Lin JC; Lai MS Ophthalmologica; 2016; 235(2):87-96. PubMed ID: 26695432 [TBL] [Abstract][Full Text] [Related]
53. [Recent intervention studies with antihypertensive drugs and their influence on guidelines]. Rahn KH Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679 [TBL] [Abstract][Full Text] [Related]
54. How to induce severe electrolyte disturbances in the elderly? Hörl WH Wien Klin Wochenschr; 2002 Nov; 114(21-22):885-6. PubMed ID: 12528317 [No Abstract] [Full Text] [Related]
55. Hypertension and renal disease risk. Eyes on the end result. Long JB Adv Nurse Pract; 2007 Aug; 15(8):30-5; quiz 36. PubMed ID: 19998973 [No Abstract] [Full Text] [Related]
56. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension. Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778 [TBL] [Abstract][Full Text] [Related]
57. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes. Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055 [TBL] [Abstract][Full Text] [Related]
58. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
59. [Do calcium antagonists should be still an initial therapy in hypertension?]. Głuszek J; Pawlaczyk-Gabriel K Pol Arch Med Wewn; 2003 Feb; 109(2):189-94. PubMed ID: 12879783 [No Abstract] [Full Text] [Related]